VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives

E-ISSN： 2212-3938|6|3|164-168

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.6, Iss.3, 2011-08, pp. : 164-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma

Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. : 189-198

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic Therapies for Metastatic Renal Cell Carcinoma in Older Adults

By Pal Sumanta K.

Drugs & Aging, Vol. 28, Iss. 8, 2011-08 ,pp. : 635-649

Adis International

Access to resources Recommend Favorite

Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma

By Sfoungaristos Stavros Giannitsas Konstantinos Perimenis Petros

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 4, 2011-03 ,pp. : 533-547

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies for renal cell carcinoma

By Seigne John Antonia Scott Fishman Mayer

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 6, 2001-06 ,pp. : 1033-1044

Informa Healthcare

Access to resources Recommend Favorite

Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives

Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. : 1058-1077

Bentham Science Publishers

Access to resources Recommend Favorite